Skip to content

A food compound with a preventive effect and / or treatment in lipid and glycemic disorders In HIV-positive individuals on antiretroviral therapy

Bioactive Compound: nutritional therapy in the lipid and glycemic alterations caused by HIV infection in individuals using combined antiretroviral therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6m2fch
Enrollment
Unknown
Registered
2017-08-29
Start date
2011-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemias, Antiretroviral Therapy, Highly Active, Functional Food.

Interventions

The Intervention Group (n = 121) received a recommendation on Lifestyle Change associated to the receipt of 03 packages with 1.2 kg each containing the Bioactive Diet Compound for consumption for 3 mo
Dietary supplement
B04.820.650.589.650.350

Sponsors

Universidade Federal de Mato Grosso do Sul
Lead Sponsor
Secretaria de Saúde Municipal de Campo Grande
Collaborator

Eligibility

Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Having aged 18 years or more; being on ART using or not lipid-lowering or hypoglycemic medications; perform laboratory tests according to request and control medical; participate from beginning to end of study and having signed the Term of Free and Informed.

Exclusion criteria

Exclusion criteria: Do not meet the inclusion protocol; Be a carrier of mental and renal diseases; Being pregnant; Be indigenous.

Design outcomes

Primary

MeasureTime frame
It is expected to reduce total cholesterol and LDL cholesterol levels assessed from biochemical tests, in relation to the values prior to intake of the bioactive compound.;It is expected a reduction in triglyceride levels evaluated from biochemical tests, in relation to the values prior to the ingestion of the bioactive compound.;Glucose levels are expected to be evaluated from biochemical tests in relation to the values prior to the ingestion of the bioactive compound.;We expect the reduction of waist-hip ratio and body mass index, measured by anthropometry, comparing the values obtained before and after consumption of the bioactive compound.

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactRosângela Ferreira

Universidade Federal de Mato Grosso do Sul

rosangela.ferreira@ufms.br+55 (67) 3345 7445

Outcome results

None listed

Source: REBEC (via WHO ICTRP)